Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning [NA]

View source ↗

Summary

Clinical trial update on the efficacy and safety of TargetCool plus Benev Exosomes in patients with hair thinning; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benev Exosomes
  • TargetCool

Snippet

Sponsor: Recens Medical, Inc. | Conditions: Hair Diseases, Alopecia | NA | Status: ACTIVE_NOT_RECRUITING